Updated recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

30 July 2021

Departmental update

Reading time:

The interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™) have been updated to reflect latest evidence.

For further information, see below:

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19

Media Contacts

WHO Media Team

World Health Organization

Email: mediainquiries@who.int